Ever Supreme Bio Technology Ltd.

Taiwan‑based Ever Supreme Bio Technology develops a diversified cell/immune‑cell pipeline with multiple Phase 1–3 candidates for cardiovascular, stroke, brain tumor and breast cancer indications, positioning for rapid commercialization.

Headquarters: Taiwan (TWN)

Ever Supreme Bio Technology Ltd. Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
6712 Ever Supreme Bio Technology Ltd.
Cap: 13.9B | P/E: 27.0
EQUITY TWO TWD TW0006712003 Active
📈
Home Login